BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Biovest International, Inc. Names Lymphoma Key Opinion Leader From MD Anderson Cancer Center to Scientific Advisory Board

  September 11, 2012

   · 

  1 min read
• Pharm Country

  CircuLite Presents Positive Hemodynamic, Exercise Tolerance and Quality of Life Data for SYNERGY® Circulatory Support System at Heart Failure Society of America Scientific Meeting

  September 11, 2012

   · 

  1 min read
• Drug Development

  Durata Therapeutics, Inc. Announces Completion of QT Study of Dalbavancin

  September 11, 2012

   · 

  1 min read
• BioForest

  Cell Therapeutics, Inc. Announces European Launch of Pixuvri® For Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphoma

  September 11, 2012

   · 

  8 min read
• Business

  Osmotica Pharmaceutical and Panacea Biotech Ltd. Announce Strategic Alliance Agreement

  September 11, 2012

   · 

  1 min read
• Business

  OncoSec Medical Inc. Secures License for Electroporation Intellectual Property From University of South Florida

  September 11, 2012

   · 

  4 min read
• Drug Development

  Karolinska Development AB: Pergamum Announces That the First Patient has Been Dosed With Potential New Treatment for Hard-to-Heal Wounds

  September 11, 2012

   · 

  1 min read
• Drug Development

  Novelos Therapeutics, Inc. Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic

  September 11, 2012

   · 

  5 min read
• Drug Development

  Kips Bay Medical Announces the First Patient Enrollment in Its U.S. Clinical Feasibility Trial in Europe

  September 11, 2012

   · 

  1 min read
• BioCapital

  Innovative Therapies Inc. (ITI) Holds Multi-Disciplinary Medical Forum to Discuss New Concepts in Negative Pressure Wound Therapy (NPWT)

  September 11, 2012

   · 

  1 min read